
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
---|---|---|---|---|---|
CE
Celanese
|
$2.5B | $1.40 | -3.15% | 61.97% | $65.71 |
CTVA
Corteva
|
$6.3B | $1.88 | 2.12% | 23.27% | $78.48 |
DOW
Dow
|
$10.2B | -$0.16 | -5.31% | -99.9% | $34.18 |
GPRE
Green Plains
|
$619.3M | -$0.34 | -6.57% | -21.28% | $9.56 |
HWKN
Hawkins
|
$278.8M | $1.37 | 8.94% | -0.73% | $148.33 |
NUE
Nucor
|
$8.5B | $2.62 | 4.35% | -16.68% | $149.99 |
Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
---|---|---|---|---|---|---|---|
CE
Celanese
|
$56.92 | $65.71 | $6.2B | 7.03x | $0.03 | 2.57% | 0.62x |
CTVA
Corteva
|
$72.98 | $78.48 | $49.8B | 44.50x | $0.17 | 0.93% | 3.00x |
DOW
Dow
|
$28.14 | $34.18 | $19.9B | 70.35x | $0.70 | 9.95% | 0.47x |
GPRE
Green Plains
|
$7.78 | $9.56 | $508.5M | -- | $0.00 | 0% | 0.21x |
HWKN
Hawkins
|
$159.86 | $148.33 | $3.3B | 39.57x | $0.18 | 0.45% | 3.43x |
NUE
Nucor
|
$137.79 | $149.99 | $31.8B | 24.52x | $0.55 | 1.59% | 1.07x |
Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
---|---|---|---|---|
CE
Celanese
|
71.14% | -0.094 | 192.54% | 1.01x |
CTVA
Corteva
|
14.39% | 1.152 | 9.45% | 0.90x |
DOW
Dow
|
48.14% | 0.278 | 61.87% | 0.82x |
GPRE
Green Plains
|
41.4% | 3.432 | 172.36% | 0.60x |
HWKN
Hawkins
|
24.43% | 1.674 | 6.79% | 1.30x |
NUE
Nucor
|
28.19% | 1.736 | 27.37% | 1.39x |
Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
---|---|---|---|---|---|---|
CE
Celanese
|
$476M | $175M | -8.42% | -24.41% | 6.99% | -$65M |
CTVA
Corteva
|
$2.1B | $827M | 3.91% | 4.6% | 18.57% | -$2.2B |
DOW
Dow
|
$671M | $29M | 0.85% | 1.6% | -1.52% | -$594M |
GPRE
Green Plains
|
$3M | -$62.3M | -7.12% | -11.81% | -10.44% | -$71.8M |
HWKN
Hawkins
|
$52.2M | $24.6M | 15.13% | 19.28% | 9.76% | $19.8M |
NUE
Nucor
|
$605M | $324M | 4.68% | 6.22% | 4.29% | -$495M |
Corteva has a net margin of -0.88% compared to Celanese's net margin of 14.76%. Celanese's return on equity of -24.41% beat Corteva's return on equity of 4.6%.
Company | Gross Margin | Earnings Per Share | Invested Capital |
---|---|---|---|
CE
Celanese
|
19.93% | -$0.19 | $18.4B |
CTVA
Corteva
|
46.98% | $0.95 | $28.6B |
Celanese has a consensus price target of $65.71, signalling upside risk potential of 15.45%. On the other hand Corteva has an analysts' consensus of $78.48 which suggests that it could grow by 7.54%. Given that Celanese has higher upside potential than Corteva, analysts believe Celanese is more attractive than Corteva.
Company | Buy Ratings | Hold Ratings | Sell Ratings |
---|---|---|---|
CE
Celanese
|
5 | 10 | 1 |
CTVA
Corteva
|
15 | 6 | 0 |
Celanese has a beta of 1.137, which suggesting that the stock is 13.731% more volatile than S&P 500. In comparison Corteva has a beta of 0.756, suggesting its less volatile than the S&P 500 by 24.37%.
Celanese has a quarterly dividend of $0.03 per share corresponding to a yield of 2.57%. Corteva offers a yield of 0.93% to investors and pays a quarterly dividend of $0.17 per share. Celanese pays -20.17% of its earnings as a dividend. Corteva pays out 50.5% of its earnings as a dividend. Corteva's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
Celanese quarterly revenues are $2.4B, which are smaller than Corteva quarterly revenues of $4.4B. Celanese's net income of -$21M is lower than Corteva's net income of $652M. Notably, Celanese's price-to-earnings ratio is 7.03x while Corteva's PE ratio is 44.50x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Celanese is 0.62x versus 3.00x for Corteva. Usually stocks with elevated PS ratios are considered overvalued.
Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
---|---|---|---|---|
CE
Celanese
|
0.62x | 7.03x | $2.4B | -$21M |
CTVA
Corteva
|
3.00x | 44.50x | $4.4B | $652M |
Dow has a net margin of -0.88% compared to Celanese's net margin of -2.94%. Celanese's return on equity of -24.41% beat Dow's return on equity of 1.6%.
Company | Gross Margin | Earnings Per Share | Invested Capital |
---|---|---|---|
CE
Celanese
|
19.93% | -$0.19 | $18.4B |
DOW
Dow
|
6.43% | -$0.44 | $32.9B |
Celanese has a consensus price target of $65.71, signalling upside risk potential of 15.45%. On the other hand Dow has an analysts' consensus of $34.18 which suggests that it could grow by 21.48%. Given that Dow has higher upside potential than Celanese, analysts believe Dow is more attractive than Celanese.
Company | Buy Ratings | Hold Ratings | Sell Ratings |
---|---|---|---|
CE
Celanese
|
5 | 10 | 1 |
DOW
Dow
|
4 | 14 | 1 |
Celanese has a beta of 1.137, which suggesting that the stock is 13.731% more volatile than S&P 500. In comparison Dow has a beta of 0.889, suggesting its less volatile than the S&P 500 by 11.13%.
Celanese has a quarterly dividend of $0.03 per share corresponding to a yield of 2.57%. Dow offers a yield of 9.95% to investors and pays a quarterly dividend of $0.70 per share. Celanese pays -20.17% of its earnings as a dividend. Dow pays out 176.17% of its earnings as a dividend.
Celanese quarterly revenues are $2.4B, which are smaller than Dow quarterly revenues of $10.4B. Celanese's net income of -$21M is higher than Dow's net income of -$307M. Notably, Celanese's price-to-earnings ratio is 7.03x while Dow's PE ratio is 70.35x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Celanese is 0.62x versus 0.47x for Dow. Usually stocks with elevated PS ratios are considered overvalued.
Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
---|---|---|---|---|
CE
Celanese
|
0.62x | 7.03x | $2.4B | -$21M |
DOW
Dow
|
0.47x | 70.35x | $10.4B | -$307M |
Green Plains has a net margin of -0.88% compared to Celanese's net margin of -12.12%. Celanese's return on equity of -24.41% beat Green Plains's return on equity of -11.81%.
Company | Gross Margin | Earnings Per Share | Invested Capital |
---|---|---|---|
CE
Celanese
|
19.93% | -$0.19 | $18.4B |
GPRE
Green Plains
|
0.51% | -$1.14 | $1.4B |
Celanese has a consensus price target of $65.71, signalling upside risk potential of 15.45%. On the other hand Green Plains has an analysts' consensus of $9.56 which suggests that it could grow by 22.99%. Given that Green Plains has higher upside potential than Celanese, analysts believe Green Plains is more attractive than Celanese.
Company | Buy Ratings | Hold Ratings | Sell Ratings |
---|---|---|---|
CE
Celanese
|
5 | 10 | 1 |
GPRE
Green Plains
|
1 | 6 | 0 |
Celanese has a beta of 1.137, which suggesting that the stock is 13.731% more volatile than S&P 500. In comparison Green Plains has a beta of 1.223, suggesting its more volatile than the S&P 500 by 22.286%.
Celanese has a quarterly dividend of $0.03 per share corresponding to a yield of 2.57%. Green Plains offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Celanese pays -20.17% of its earnings as a dividend. Green Plains pays out -6.26% of its earnings as a dividend.
Celanese quarterly revenues are $2.4B, which are larger than Green Plains quarterly revenues of $601.5M. Celanese's net income of -$21M is higher than Green Plains's net income of -$72.9M. Notably, Celanese's price-to-earnings ratio is 7.03x while Green Plains's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Celanese is 0.62x versus 0.21x for Green Plains. Usually stocks with elevated PS ratios are considered overvalued.
Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
---|---|---|---|---|
CE
Celanese
|
0.62x | 7.03x | $2.4B | -$21M |
GPRE
Green Plains
|
0.21x | -- | $601.5M | -$72.9M |
Hawkins has a net margin of -0.88% compared to Celanese's net margin of 6.66%. Celanese's return on equity of -24.41% beat Hawkins's return on equity of 19.28%.
Company | Gross Margin | Earnings Per Share | Invested Capital |
---|---|---|---|
CE
Celanese
|
19.93% | -$0.19 | $18.4B |
HWKN
Hawkins
|
21.29% | $0.78 | $609.1M |
Celanese has a consensus price target of $65.71, signalling upside risk potential of 15.45%. On the other hand Hawkins has an analysts' consensus of $148.33 which suggests that it could fall by -7.21%. Given that Celanese has higher upside potential than Hawkins, analysts believe Celanese is more attractive than Hawkins.
Company | Buy Ratings | Hold Ratings | Sell Ratings |
---|---|---|---|
CE
Celanese
|
5 | 10 | 1 |
HWKN
Hawkins
|
0 | 0 | 0 |
Celanese has a beta of 1.137, which suggesting that the stock is 13.731% more volatile than S&P 500. In comparison Hawkins has a beta of 0.852, suggesting its less volatile than the S&P 500 by 14.832%.
Celanese has a quarterly dividend of $0.03 per share corresponding to a yield of 2.57%. Hawkins offers a yield of 0.45% to investors and pays a quarterly dividend of $0.18 per share. Celanese pays -20.17% of its earnings as a dividend. Hawkins pays out 17.35% of its earnings as a dividend. Hawkins's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
Celanese quarterly revenues are $2.4B, which are larger than Hawkins quarterly revenues of $245.3M. Celanese's net income of -$21M is lower than Hawkins's net income of $16.3M. Notably, Celanese's price-to-earnings ratio is 7.03x while Hawkins's PE ratio is 39.57x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Celanese is 0.62x versus 3.43x for Hawkins. Usually stocks with elevated PS ratios are considered overvalued.
Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
---|---|---|---|---|
CE
Celanese
|
0.62x | 7.03x | $2.4B | -$21M |
HWKN
Hawkins
|
3.43x | 39.57x | $245.3M | $16.3M |
Nucor has a net margin of -0.88% compared to Celanese's net margin of 1.99%. Celanese's return on equity of -24.41% beat Nucor's return on equity of 6.22%.
Company | Gross Margin | Earnings Per Share | Invested Capital |
---|---|---|---|
CE
Celanese
|
19.93% | -$0.19 | $18.4B |
NUE
Nucor
|
7.73% | $0.67 | $29B |
Celanese has a consensus price target of $65.71, signalling upside risk potential of 15.45%. On the other hand Nucor has an analysts' consensus of $149.99 which suggests that it could grow by 8.85%. Given that Celanese has higher upside potential than Nucor, analysts believe Celanese is more attractive than Nucor.
Company | Buy Ratings | Hold Ratings | Sell Ratings |
---|---|---|---|
CE
Celanese
|
5 | 10 | 1 |
NUE
Nucor
|
7 | 4 | 0 |
Celanese has a beta of 1.137, which suggesting that the stock is 13.731% more volatile than S&P 500. In comparison Nucor has a beta of 1.705, suggesting its more volatile than the S&P 500 by 70.46%.
Celanese has a quarterly dividend of $0.03 per share corresponding to a yield of 2.57%. Nucor offers a yield of 1.59% to investors and pays a quarterly dividend of $0.55 per share. Celanese pays -20.17% of its earnings as a dividend. Nucor pays out 25.75% of its earnings as a dividend. Nucor's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
Celanese quarterly revenues are $2.4B, which are smaller than Nucor quarterly revenues of $7.8B. Celanese's net income of -$21M is lower than Nucor's net income of $156M. Notably, Celanese's price-to-earnings ratio is 7.03x while Nucor's PE ratio is 24.52x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Celanese is 0.62x versus 1.07x for Nucor. Usually stocks with elevated PS ratios are considered overvalued.
Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
---|---|---|---|---|
CE
Celanese
|
0.62x | 7.03x | $2.4B | -$21M |
NUE
Nucor
|
1.07x | 24.52x | $7.8B | $156M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.